Copyright
©The Author(s) 2025.
World J Hepatol. May 27, 2025; 17(5): 104519
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.104519
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.104519
Table 1 Baseline characteristics of patients
| Patients | n = 13 |
| Sex (male/female) | 8/5 |
| Age (year), median (range) | 40 (30–62) |
| Genotype (A/B/C) | 1/0/12 |
| HBsAg (IU/mL), median (range) | 5037.79 (605.77-139448.20) |
| Positive for HBeAg | 8 (61.5%) |
| ALT (U/L), median (range) | 64 (24–591) |
| HBV DNA (log IU/mL), median (range) | 6.6 (1.6–9.1) |
- Citation: Yamada N, Igarashi H, Murayama A, Suzuki M, Yasuda K, Saito M, Isogawa M, Kato T. Deep sequencing analysis of hepatitis B virus in patients with incomplete response to tenofovir alafenamide fumarate treatment. World J Hepatol 2025; 17(5): 104519
- URL: https://www.wjgnet.com/1948-5182/full/v17/i5/104519.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i5.104519